Literature DB >> 8303620

Leukotrienes and aspirin induced asthma.

T H Lee, P E Christie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8303620      PMCID： PMC464963          DOI： 10.1136/thx.48.12.1189

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  28 in total

1.  Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma.

Authors:  S R Findlay; J M Barden; C B Easley; M Glass
Journal:  J Allergy Clin Immunol       Date:  1992-05       Impact factor: 10.793

2.  Urinary leukotriene E4 levels after allergen and exercise challenge in bronchial asthma.

Authors:  C M Smith; P E Christie; R J Hawksworth; F Thien; T H Lee
Journal:  Am Rev Respir Dis       Date:  1991-12

3.  Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.

Authors:  B Dahlén; D J Margolskee; O Zetterström; S E Dahlén
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

4.  Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects.

Authors:  P E Christie; P Tagari; A W Ford-Hutchinson; C Black; A Markendorf; M Schmitz-Schumann; T H Lee
Journal:  Am Rev Respir Dis       Date:  1992-12

5.  The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.

Authors:  B Dahlén; M Kumlin; D J Margolskee; C Larsson; H Blomqvist; V C Williams; O Zetterström; S E Dahlén
Journal:  Eur Respir J       Date:  1993-07       Impact factor: 16.671

6.  Leukotriene E4 and granulocytic infiltration into asthmatic airways.

Authors:  L A Laitinen; A Laitinen; T Haahtela; V Vilkka; B W Spur; T H Lee
Journal:  Lancet       Date:  1993-04-17       Impact factor: 79.321

7.  Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.

Authors:  M Kumlin; B Dahlén; T Björck; O Zetterström; E Granström; S E Dahlén
Journal:  Am Rev Respir Dis       Date:  1992-07

8.  Urinary leukotriene E4 in bronchial asthma.

Authors:  C M Smith; R J Hawksworth; F C Thien; P E Christie; T H Lee
Journal:  Eur Respir J       Date:  1992-06       Impact factor: 16.671

9.  Increased excretion of leukotriene E4 during aspirin-induced asthma.

Authors:  H R Knapp; K Sladek; G A Fitzgerald
Journal:  J Lab Clin Med       Date:  1992-01

10.  Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.

Authors:  J N Gaddy; D J Margolskee; R K Bush; V C Williams; W W Busse
Journal:  Am Rev Respir Dis       Date:  1992-08
View more
  4 in total

Review 1.  The use of analgesics in patients with asthma.

Authors:  S Levy; G Volans
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Drug treatment of asthma in the 1990s: achievements and new strategies.

Authors:  A Tavakkoli; P J Rees
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

Review 3.  Desensitization for the prevention of drug hypersensitivity reactions.

Authors:  Sung-Yoon Kang; Jeongmin Seo; Hye-Ryun Kang
Journal:  Korean J Intern Med       Date:  2022-02-28       Impact factor: 2.884

Review 4.  Update on the Management of Nonsteroidal Anti-Inflammatory Drug Hypersensitivity.

Authors:  Wan Yin Winnie Yeung; Hae Sim Park
Journal:  Yonsei Med J       Date:  2020-01       Impact factor: 2.759
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.